aiCockpit AI Viewer
Fovia, Inc. • Radiology • 02/26/2025
Device Purpose
The Fovia, Inc. aiCockpit AI Viewer is a medical image management and processing system designed to enhance clinical review by integrating artificial intelligence software with advanced 3D rendering capabilities. It functions as an overlay on DICOM images, providing annotations and measurements, thereby aiding clinicians in reviewing findings by presenting imaging data alongside clinical documents.
Summary
On February 26, 2025, a determination was issued regarding Fovia, Inc.'s aiCockpit AI Viewer, confirming it is substantially equivalent to legally marketed products. This device is a medical image management and processing system designed for clinical review in General Radiology and other healthcare imaging applications. It functions as software that displays annotations and measurements as an overlay on images from DICOM objects and artificial intelligence software. The viewer also supports 3D Multi-Planar Reformatting, 3D Maximum Intensity Projection, and 3D Volume Rendering, and aids in reviewing findings by presenting clinical documents and reports alongside images. It is intended for use with off-the-shelf computing devices and supports major desktop browsers.Companies marketing such devices must adhere to ongoing regulatory requirements, including annual registration, device listing, good manufacturing practices, and specific labeling rules. The determination of equivalence does not imply compliance with all other federal statutes, and manufacturers must also comply with quality system regulations, covering aspects like design controls and corrective actions. Additionally, the aiCockpit AI Viewer is subject to Unique Device Identification System regulations, requiring specific labeling and database submissions. Resources are available for information on changes that may require further review, adverse event reporting, and comprehensive regulatory assistance.
AI Regulatory Concerns
Powered by
Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.
Keywords
Device Metadata
Relevant Clinical Questions
- Q1. How does the aiCockpit AI Viewer's AI software integrate with existing clinical workflows and what specific diagnostic improvements does it offer over traditional image viewers?; What are the performance metrics (e.g., accuracy, speed, latency) of the AI annotations and measurements displayed by the viewer, particularly in diverse clinical scenarios?; Beyond General Radiology, what other specific healthcare imaging applications is the aiCockpit AI Viewer optimized for, and are there any ongoing clinical trials supporting its efficacy in these areas?; What cybersecurity measures are in place to protect patient data and DICOM objects when using the aiCockpit AI Viewer with off-the-shelf computing devices and web browsers?; Given its substantial equivalence, what post-market surveillance data is required or being collected to monitor the long-term performance and safety of the aiCockpit AI Viewer in clinical use?
Risk Classification
ESL AnalysisFDA Class II via 510(k) pathway; IEC 62304 Class B (software safety classification); Post-§524B but no clear network capability detected
Learn how Parasoft automates IEC 62304 compliance testing →Cybersecurity Evidence
Powered by SBOMator™Based on AI-generated device summaries, not the full FDA submission. Items not detected here may still be present in the complete submission package.
Supply Chain BOM Evidence
Based on the CycloneDX / OWASP ECMA-424 xBOM ecosystem. Detection is from the AI-generated summary.
Analysis:
• Analysis is based on the AI-generated device summary, not the full FDA submission package. Click "Analyze Full FDA PDF" below to scan the actual submission document.
• Evidence of ML-BOM detected in AI-generated device summary.
• SBOM not mentioned in AI-generated device summary. Under §524B (effective Oct 2023), cyber devices must provide a SBOM.
• Not detected in AI-generated device summary: SBOM, SaaSBOM, HBOM, CBOM, VDR/VEX, OBOM. These may be present in the full FDA submission.
Preparing a similar submission?
ESL takes complete ownership of your software evidence work - SBOM & CVE remediation with SBOMator™, static analysis & unit testing with Parasoft, traceability, and full IEC 62304 lifecycle support.
Assess Your Readiness →Or contact ESL directly